As of January 22, 2025, Arvinas (ARVN) has a market cap of $1.27 billion USD. According to our data, Arvinas is ranked No.4853 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.27 B |
-3.76%
|
Dec 31, 2024 | $1.32 B |
-53.43%
|
Dec 29, 2023 | $2.83 B |
20.32%
|
Dec 30, 2022 | $2.35 B |
-58.35%
|
Dec 31, 2021 | $5.64 B |
-3.29%
|
Dec 31, 2020 | $5.84 B |
106.69%
|
Dec 31, 2019 | $2.82 B |
219.77%
|
Dec 31, 2018 | $0.88 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Market Cap | = | ARVN Stock Price | * | ARVN Shares Outstanding |
= | $18.45 | * | 68.71 M | |
= | $1.27 B |